Deutsche Bank’s Synergy Pharmaceuticals SGYP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-327,995
Closed -$36K – 5612
2018
Q4
$36K Sell
327,995
-683,520
-68% -$449K ﹤0.01% 4596
2018
Q3
$1.72M Buy
1,011,515
+158,083
+19% +$283K ﹤0.01% 2958
2018
Q2
$1.48M Sell
853,432
-454,611
-35% -$786K ﹤0.01% 3151
2018
Q1
$2.39M Sell
1,308,043
-853,486
-39% -$1.8M ﹤0.01% 2741
2017
Q4
$4.82M Sell
2,161,529
-222,471
-9% -$553K ﹤0.01% 2067
2017
Q3
$6.91M Buy
2,384,000
+1,337,095
+128% +$4.56M ﹤0.01% 1703
2017
Q2
$4.66M Buy
1,046,905
+738,906
+240% +$3.05M ﹤0.01% 1975
2017
Q1
$1.43M Buy
307,999
+176,995
+135% +$1.03M ﹤0.01% 2437
2016
Q4
$796K Sell
131,004
-765,489
-85% -$4M ﹤0.01% 2858
2016
Q3
$4.94M Buy
896,493
+29,777
+3% +$139K ﹤0.01% 1734
2016
Q2
$3.29M Buy
866,716
+244,672
+39% +$829K ﹤0.01% 2056
2016
Q1
$1.72M Sell
622,044
-96,406
-13% -$349K ﹤0.01% 2475
2015
Q4
$4.07M Sell
718,450
-260,682
-27% -$1.59M ﹤0.01% 1934
2015
Q3
$5.19M Buy
979,132
+902,736
+1,182% +$6.99M ﹤0.01% 1789
2015
Q2
$633K Buy
76,396
+6,890
+10% +$33.4K ﹤0.01% 3266
2015
Q1
$318K Sell
69,506
-42,275
-38% -$137K ﹤0.01% 3544
2014
Q4
$339K Buy
111,781
+63,139
+130% +$187K ﹤0.01% 3957
2014
Q3
$134K Buy
48,642
+17,857
+58% +$64.8K ﹤0.01% 4322
2014
Q2
$124K Sell
30,785
-82,234
-73% -$349K ﹤0.01% 4428
2014
Q1
$599K Buy
113,019
+13,649
+14% +$76.5K ﹤0.01% 3219
2013
Q4
$551K Sell
99,370
-404,735
-80% -$1.75M ﹤0.01% 3039
2013
Q3
$2.27M Buy
504,105
+49,087
+11% +$220K ﹤0.01% 2395
2013
Q2
$1.94M Buy
+455,018
New +$2.29M ﹤0.01% 2243

Other funds holding SGYP

Deutsche Bank's SGYP Position: Q1 2019 in Review

Deutsche Bank sold out of Synergy Pharmaceuticals (SGYP) in Q1 2019, closing a stake of 327,995 shares — an estimated $36K sold.

Deutsche Bank first reported a position in SGYP in Q2 2013 and held it in 23 quarters. The position peaked at $6.91M in Q3 2017. 12 funds tracked by Wall St. Rank hold SGYP as of Q1 2019.

  • Deutsche Bank reported no remaining Synergy Pharmaceuticals position as of Q1 2019 after selling out during the quarter.
  • Deutsche Bank sold 327,995 Synergy Pharmaceuticals shares in Q1 2019, an estimated $36K.
  • Deutsche Bank first reported a position in Synergy Pharmaceuticals in Q2 2013 and held it in 23 quarters.
  • Deutsche Bank's Synergy Pharmaceuticals position peaked at $6.91M in Q3 2017.
  • 12 funds tracked by Wall St. Rank held Synergy Pharmaceuticals as of Q1 2019.

Based on Deutsche Bank's 13F filing for Q1 2019, filed 15 May 2019.